Sanofi, Merck JV Recalls Faulty Typhoid Vaccine, UK Says

Law360, New York (October 9, 2012, 2:07 PM EDT) -- A Sanofi SA and Merck & Co. vaccine manufacturing joint venture has recalled 16 batches of typhoid vaccine after determining discrepancies in the manufacturing process may diminish its effectiveness, resulting in an expected shortage of the product, a British drug regulator announced Monday. 

The Medicines and Healthcare Products Regulatory Agency, or MHRA, issued a drug alert to health care professionals saying that Sanofi Pasteur MSD recalled the batches of its Typhim Vi vaccine distributed since January 2011 after recent investigations indicated some of the syringes could...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.